Spironolactone and Hair Loss: The Drug That Both Causes It and Treats It

Does Spironolactone Cause Hair Loss?

Spironolactone sits in an unusual position in the hair loss conversation. It appears on lists of medications that cause hair loss and also on lists of treatments dermatologists prescribe for hair loss. Both are accurate. The outcome depends entirely on why you're taking it and what's driving your hair loss.

What Spironolactone Is and How It Works

Spironolactone (brand name Aldactone) is primarily a potassium-sparing diuretic prescribed for high blood pressure and heart failure. It also has significant anti-androgenic properties: it blocks androgen receptors and weakly inhibits androgen production, which is why it has been used off-label for years to treat hormonally-driven acne and female pattern hair loss.

When Spironolactone Is Used to Treat Hair Loss

For women with female pattern hair loss driven by androgen excess, spironolactone can reduce the androgenic pressure on hair follicles by blocking DHT's effect at the receptor. A systematic review of oral and topical spironolactone for androgenetic alopecia found it to be an effective option for women who did not respond well to topical minoxidil.

A 2024 randomized, double-blind, placebo-controlled pilot study found that oral spironolactone 100mg daily combined with topical minoxidil improved hair density and diameter in premenopausal women over 24 weeks. A UCLA study of 166 women found that 74.3% of patients reported stabilization or improvement in hair loss.

When Spironolactone May Cause or Worsen Hair Loss

For men, spironolactone's anti-androgenic effects can cause scalp and body hair changes — it is rarely prescribed for hair loss in men. For women at the beginning of treatment, an increase in shedding during the first four to eight weeks as the hair cycle adjusts is common. This is a transitional response, not a sign of ongoing damage.

Side Effects Women Should Know

  • Menstrual irregularities in roughly one-third of users
  • Hyperkalemia (elevated potassium): rare but serious, particularly with kidney disease or potassium supplements
  • Dizziness and lightheadedness at higher doses
  • Not safe during pregnancy: contraindicated in women actively trying to conceive
  • Breast tenderness in some users

Supporting Hair Alongside Spironolactone

Nutritional support matters alongside any prescription approach. Women's Growth Complex provides zinc, selenium, and Cynatine HNS to support the follicle environment. For a broader overview of how androgens drive hair loss in women, see the testosterone and hair loss in women post.

Two Sides, One Drug

Spironolactone's relationship with hair reflects how much context matters in hormonal hair loss. For women with androgen-driven female pattern hair loss, it can meaningfully slow or stop progression. For the wrong patient or without attention to side effects, it adds complexity without benefit. The decision belongs with a dermatologist who can assess your specific hormonal picture.

Frequently Asked Questions

Does spironolactone cause initial shedding?

An increase in shedding during the first four to eight weeks is common and generally a transitional response. Most users who respond see shedding normalize and density improve by months three to six.

How long does spironolactone take to work for hair?

Most clinical evidence shows measurable improvements in hair density between three and twelve months of consistent use.

Can men take spironolactone for hair loss?

Rarely. Its anti-androgenic effects at therapeutic doses can cause feminizing side effects. Finasteride and dutasteride are the standard DHT-blocking options for men.

What dose is effective for hair loss?

Studies showing efficacy primarily used 100mg daily. Doses below 100mg have generally been found ineffective for altering the hair loss pattern.

Can I take it if I'm trying to conceive?

No. Spironolactone is contraindicated in pregnancy and women actively trying to conceive due to the risk of feminizing a male fetus.

Sources

  1. Fabbrocini G, et al. Efficacy and safety of oral and topical spironolactone in AGA. PMC. 2023.
  2. Mekkes JR, et al. Oral spironolactone RCT for female pattern hair loss. PMC. 2025.
  3. Rathnayake D & Sinclair R. Spironolactone therapy in FPHL. PMC. 2015.

More From HAIRLOVE